We are live on ! Find out more
GEN

Genesis Healthcare, Inc.
GEN

Delisted

GEN was delisted on the 25th of March, 2021.

Back to rankings

2 hedge funds and large institutions have $11 invested in Genesis Healthcare, Inc. in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WPW
Waldron Private Wealth
Pennsylvania
+$11

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
WPW
1
Waldron Private Wealth
Pennsylvania
$11 +$11 +10,000 New

GEN Hedge Fund Activity: Q1 2024 in Review

2 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q1 2024, worth a combined $11.

Buyers outnumbered sellers: 1 fund opened new GEN positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Waldron Private Wealth, opening a new position worth an estimated $11.

  • 2 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q1 2024, up from 1 in Q4 2023.
  • Funds reported $11 of Genesis Healthcare, Inc. stock for Q1 2024.
  • 1 fund opened new Genesis Healthcare, Inc. positions in Q1 2024 and 0 closed out, a net change of +1 holder.
  • The largest Genesis Healthcare, Inc. buyer in Q1 2024 was Waldron Private Wealth, an estimated $11 added.

Based on aggregated 13F filings for Q1 2024.